Translational reprogramming of colorectal cancer cells induced by 5-fluorouracil through a miRNA-dependent mechanism

被引:23
|
作者
Bash-Imam, Zeina [1 ]
Therizols, Gabriel [1 ]
Vincent, Anne [1 ]
Laforets, Florian [1 ]
Espinoza, Micaela Polay [1 ]
Pion, Nathalie [1 ]
Macari, Francoise [4 ]
Pannequin, Julie [4 ]
David, Alexandre [4 ]
Saurin, Jean-Christophe [1 ]
Mertani, Hichem C. [1 ]
Textoris, Julien [3 ]
Auboeuf, Didier [1 ]
Catez, Frederic [1 ]
Venezia, Nicole Dalla [1 ]
Dutertre, Martin [2 ]
Marcel, Virginie [1 ]
Diaz, Jean-Jacques [1 ]
机构
[1] Univ Lyon 1, INSERM 1052, CNRS 5286, Ctr Leon Berard,Ctr Rech Cancerol Lyon, F-69373 Lyon, France
[2] Ctr Univ Orsay, CNRS UMR 3348, Inst Curie, F-91405 Orsay, France
[3] Univ Lyon 1, Hosp Civils Lyon, bioMerieux SA Pathophysiol Injury Induced Immunos, EA7426, F-69003 Lyon, France
[4] Univ Montpellier, INSERM, CNRS, IGF, F-34094 Montpellier, France
关键词
5-fluorouracil; translation; translatome profiling; miRNA; colorectal cancer; RNA METHYLATION; GENE; IDENTIFICATION; CYTOTOXICITY; FLUOROURACIL; INHIBITION; APOPTOSIS; TARGETS; DNA;
D O I
10.18632/oncotarget.17597
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5-fluorouracil (5-FU) is a widely used chemotherapeutic drug in colorectal cancer. Previous studies showed that 5-FU modulates RNA metabolism and mRNA expression. In addition, it has been reported that 5-FU incorporates into the RNAs constituting the translational machinery and that 5-FU affects the amount of some mRNAs associated with ribosomes. However, the impact of 5-FU on translational regulation remains unclear. Using translatome profiling, we report that a clinically relevant dose of 5-FU induces a translational reprogramming in colorectal cancer cell lines. Comparison of mRNA distribution between polysomal and non-polysomal fractions in response to 5-FU treatment using microarray quantification identified 313 genes whose translation was selectively regulated. These regulations were mostly stimulatory (91%). Among these genes, we showed that 5-FU increases the mRNA translation of HIVEP2, which encodes a transcription factor whose translation in normal condition is known to be inhibited by mir-155. In response to 5-FU, the expression of mir-155 decreases thus stimulating the translation of HIVEP2 mRNA. Interestingly, the 5-FU-induced increase in specific mRNA translation was associated with reduction of global protein synthesis. Altogether, these findings indicate that 5-FU promotes a translational reprogramming leading to the increased translation of a subset of mRNAs that involves at least for some of them, miRNA-dependent mechanisms. This study supports a still poorly evaluated role of translational control in drug response.
引用
收藏
页码:46219 / 46233
页数:15
相关论文
共 50 条
  • [41] Irinotecan and 5-fluorouracil in colorectal cancer: Time for a pause?
    Bulusu, VR
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (03) : 286 - 289
  • [42] ARTERIAL INJECTION OF 5-FLUOROURACIL IN COLORECTAL-CANCER
    BALL, B
    MANN, V
    CLIFTON, A
    BAKER, N
    GOODE, W
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1989, 8 (02) : 123 - 128
  • [43] CISPLATIN + 5-FLUOROURACIL VERSUS 5-FLUOROURACIL ALONE IN ADVANCED COLORECTAL-CANCER - A RANDOMIZED STUDY
    LABIANCA, R
    PANCERA, G
    CESANA, B
    CLERICI, M
    MONTINARI, F
    LUPORINI, G
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (10): : 1579 - 1581
  • [44] Macrophages induce resistance to 5-fluorouracil chemotherapy in colorectal cancer through the release of putrescine
    Zhang, Xuan
    Chen, Yujuan
    Hao, Lijun
    Hou, Along
    Chen, Xiaozhen
    Li, Yifei
    Wang, Rui
    Luo, Peng
    Ruan, Zhihua
    Ou, Juanjuan
    Shi, Chunmeng
    Miao, Hongming
    Liang, Houjie
    CANCER LETTERS, 2016, 381 (02) : 305 - 313
  • [45] Rosiglitazone enhances the apoptotic effect of 5-fluorouracil in colorectal cancer cells with high-glucose-induced glutathione
    Lau, Meng-Fei
    Chua, Kek-Heng
    Sabaratnam, Vikineswary
    Kuppusamy, Umah Rani
    SCIENCE PROGRESS, 2020, 103 (01)
  • [46] Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells
    Chong-Zhi Wang
    Xiaoji Luo
    Bin Zhang
    Wen-Xin Song
    Ming Ni
    Sangeeta Mehendale
    Jing-Tian Xie
    Han H. Aung
    Tong-Chuan He
    Chun-Su Yuan
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 69 - 79
  • [47] Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells
    Wang, Chong-Zhi
    Luo, Xiaoji
    Zhang, Bin
    Song, Wen-Xin
    Mehendale, Sangeeta
    Xie, Jing-Tian
    Aung, Han H.
    He, Tong-Chuan
    Yuan, Chun-Su
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) : 69 - 79
  • [48] Selumetinib overcomes ITGA2-induced 5-fluorouracil resistance in colorectal cancer
    Qin, Jian
    Hu, Shangshang
    Lou, Jinwei
    Xu, Mu
    Gao, Rui
    Xiao, Qianni
    Chen, Yuhan
    Ding, Muzi
    Pan, Yuqin
    Wang, Shukui
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 137
  • [49] Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer
    I Chau
    A Webb
    D Cunningham
    M Hill
    J S Waters
    A Norman
    A Massey
    British Journal of Cancer, 2001, 85 : 1258 - 1264
  • [50] Biochemical modulation of 5-fluorouracil with methotrexate in advanced colorectal cancer patients pretreated with adjuvant 5-fluorouracil and leucovorin
    Pronzato, P
    Vaira, F
    Vigani, A
    Losardo, P
    Bertelli, G
    ANTICANCER RESEARCH, 1995, 15 (6B) : 2679 - 2682